Genelabs
Executive Summary
James Andress, who headed Beecham's worldwide pharmaceutical business prior to the company's merger with SmithKline, named to the board of the privately held biotechnology company. Prior to joining Beecham, Andress served as president and chief operating officer at Sterling Drug. He currently is president and CEO of Information Resources, Inc.